Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Allen

Showing results (181-190 of 220) with videos related to

Pageof 22
Sort By:
Journal of Virology|February 1, 2013
HLA-B*57 versus HLA-B*81 in HIV-1 infection: slow and steady wins the race?Heather A Prentice, Travis R Porter, Matthew A Price, et al.
Epidemiology (Cambridge, Mass.)|November 29, 2016
Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African CountriesKristin M Wall, Wasima Rida, Lisa B Haddad, et al.
Journal of Virology|March 16, 2007
Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1Rong Rong, S Gnanakaran, Julie M Decker, et al.
The Journal of Experimental Medicine|March 25, 2009
Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipientsHayley Crawford, Wendy Lumm, Alasdair Leslie, et al.
Virus Evolution|January 21, 2026
Single genome amplification and molecular cloning of HIV-1 populations in acute HIV-1 infection: implications for studies on HIV-1 diversity and evolutionary rateAnthony Y Y Hsieh, Amin S Hassan, Jamirah Nazziwa, et al.
Nature Medicine|September 8, 2025
Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trialJulien Nyombayire, Rosine Ingabire, Amelia Mazzei, et al.
Journal of Clinical Microbiology|November 13, 2009
HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infectionSurender Khurana, Philip J Norris, Michael P Busch, et al.
The Journal of Experimental Medicine|August 24, 2016
Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progressionDaniela C Mónaco, Dario A Dilernia, Andrew Fiore-Gartland, et al.
Pilot and Feasibility Studies|March 23, 2018
Prehospital recognition and antibiotics for 999 patients with sepsis: protocol for a feasibility studyChris Moore, Jenna Bulger, Matt Morgan, et al.
The Journal of Experimental Medicine|May 4, 2005
Antigenic conservation and immunogenicity of the HIV coreceptor binding siteJulie M Decker, Frederic Bibollet-Ruche, Xiping Wei, et al.
Pageof 22

Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
Journal of Virology|February 1, 2013
HLA-B*57 versus HLA-B*81 in HIV-1 infection: slow and steady wins the race?Heather A Prentice, Travis R Porter, Matthew A Price, et al.
Epidemiology (Cambridge, Mass.)|November 29, 2016
Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African CountriesKristin M Wall, Wasima Rida, Lisa B Haddad, et al.
Journal of Virology|March 16, 2007
Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1Rong Rong, S Gnanakaran, Julie M Decker, et al.
The Journal of Experimental Medicine|March 25, 2009
Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipientsHayley Crawford, Wendy Lumm, Alasdair Leslie, et al.
Virus Evolution|January 21, 2026
Single genome amplification and molecular cloning of HIV-1 populations in acute HIV-1 infection: implications for studies on HIV-1 diversity and evolutionary rateAnthony Y Y Hsieh, Amin S Hassan, Jamirah Nazziwa, et al.
Nature Medicine|September 8, 2025
Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trialJulien Nyombayire, Rosine Ingabire, Amelia Mazzei, et al.
Journal of Clinical Microbiology|November 13, 2009
HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infectionSurender Khurana, Philip J Norris, Michael P Busch, et al.
The Journal of Experimental Medicine|August 24, 2016
Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progressionDaniela C Mónaco, Dario A Dilernia, Andrew Fiore-Gartland, et al.
Pilot and Feasibility Studies|March 23, 2018
Prehospital recognition and antibiotics for 999 patients with sepsis: protocol for a feasibility studyChris Moore, Jenna Bulger, Matt Morgan, et al.
The Journal of Experimental Medicine|May 4, 2005
Antigenic conservation and immunogenicity of the HIV coreceptor binding siteJulie M Decker, Frederic Bibollet-Ruche, Xiping Wei, et al.
Pageof 22